Published in Stroke on December 01, 2001
The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis. PLoS One (2014) 0.87
HPA-1 polymorphism of alphaIIbbeta3 modulates platelet adhesion onto immobilized fibrinogen in an in-vitro flow system. Thromb J (2007) 0.83
Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.82
Genetics of atherothrombotic and lacunar stroke. Circ Cardiovasc Genet (2009) 0.80
Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arterioscler Thromb Vasc Biol (2010) 0.78
Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes. Iran J Med Sci (2013) 0.78
Hyperhomocysteinemia exacerbates the development of intimal hyperplasia in Sprague-Dawley rats: Alleviation by rosiglitazone. Exp Clin Cardiol (2005) 0.75
Can Orthopantomography be used as a tool for screening of carotid atheromatous pathology and thus be used to help reduce the prevalence of ischemic stroke within the population? J Clin Exp Dent (2012) 0.75
Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet (1999) 7.02
Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67
Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc Natl Acad Sci U S A (1978) 6.38
Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell (1981) 6.31
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology (1999) 5.34
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med (1976) 5.13
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell (1986) 4.68
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol (1997) 4.51
The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell (1988) 4.34
Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines. Mol Cell Biol (1982) 4.26
The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand (1986) 4.12
Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell (1982) 3.86
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med (1988) 3.62
In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.47
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
The effect of helper virus on Abelson virus-induced transformation of lymphoid cells. J Exp Med (1978) 3.25
Mechanisms of adhesion among cells from neural tissues of the chick embryo. Proc Natl Acad Sci U S A (1976) 3.25
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Immunoglobulin heavy-chain expression and class switching in a murine leukaemia cell line. Nature (1982) 3.05
Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr (1994) 2.79
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial. Diabetologia (2013) 2.67
Are endoscopic measurements of colonic polyps reliable? Am J Gastroenterol (1993) 2.64
Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. EMBO J (1986) 2.62
The need for liver transplantation: a nationwide estimate based on consensus review. Lancet (1995) 2.58
Concerted deletions and inversions are caused by mitotic recombination between delta sequences in Saccharomyces cerevisiae. Mol Cell Biol (1987) 2.56
Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell (1983) 2.54
Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface. J Virol (1979) 2.50
Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial. BMJ (1998) 2.39
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38
Human immunodeficiency virus and drug misuse: the Edinburgh experience. Br Med J (Clin Res Ed) (1987) 2.37
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci U S A (1990) 2.36
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell (1998) 2.34
Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta (1970) 2.33
Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet (1998) 2.27
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
The cytoplasmic domain mediates localization of furin to the trans-Golgi network en route to the endosomal/lysosomal system. J Cell Biol (1994) 2.25
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax (2001) 2.24
A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. Proc Natl Acad Sci U S A (1980) 2.16
Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule. J Virol (1980) 2.16
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost (2009) 2.14
Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. Diabetes Educ (2002) 2.12
Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology (2000) 2.12
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
Prediction of immediate postoperative pain using the analgesia/nociception index: a prospective observational study. Br J Anaesth (2013) 2.08
Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation (1991) 2.04
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity. J Virol (1984) 1.93
SAM2 encodes the second methionine S-adenosyl transferase in Saccharomyces cerevisiae: physiology and regulation of both enzymes. Mol Cell Biol (1988) 1.87
An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev (1994) 1.85
Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry (1986) 1.83
Prescribing of quinine and cramp inducing drugs in general practice. BMJ (1995) 1.82
The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer (1999) 1.80
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells. J Virol (1981) 1.73
p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci U S A (1998) 1.73
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry (1996) 1.71
Maternal narcotic abuse and the newborn. Arch Dis Child (1988) 1.66
Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol Cell Biol (1989) 1.64
Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants. J Pediatr (1997) 1.62
Juvenile angiofibroma: a review of the literature and a case series report. Laryngoscope (1992) 1.61
A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry (1991) 1.61
Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol (2002) 1.60
Transformation of immature lymphoid cells by Abelson murine leukemia virus. Immunol Rev (1979) 1.58
Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med (1991) 1.56
Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) (1999) 1.54
A unified perspective on copper deficiency and cardiomyopathy. Proc Soc Exp Biol Med (1993) 1.52
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
Trauma in infants less than three months of age. Pediatr Emerg Care (1993) 1.50
Sclerosteosis - an autosomal recessive disorder. Clin Genet (1977) 1.50
Abelson leukemia virus induces lymphoid and erythroid colonies in infected fetal cell cultures. Cell (1981) 1.50
Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49
Prevalence of HIV antibodies in transsexual and female prostitutes. Am J Public Health (1992) 1.47
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial. Diabetes Metab Res Rev (2013) 1.47
Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost (2011) 1.46
Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost (2003) 1.45
A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states. Am J Clin Pathol (1987) 1.44
Leukemogenicity of clonal isolates of murine leukemia viruses. J Natl Cancer Inst (1978) 1.44
Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics (1995) 1.43
Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries. Occup Environ Med (2011) 1.43
Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med (2006) 1.42
The effect of a new rigid gas-permeable contact lens design on lactic dehydrogenase activity in rabbit tears. Isr Med Assoc J (2000) 1.41
The effect of intracervical vasopressin on the systemic absorption of glycine during hysteroscopic endometrial ablation. Obstet Gynecol (1996) 1.40
The role of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology (2000) 1.40
Antibodies reactive with cell surface carbohydrates. Proc Natl Acad Sci U S A (1975) 1.39
A psychodynamic perspective on the clinical impact of insurance review. Am J Psychiatry (1991) 1.39